Logo of Caribou Biosciences

Remote Jobs at Caribou Biosciences

Transformative therapies development

Next-generation CRISPR genome editing
allogeneic CAR-T cell therapies
oncology
autoimmune

About Caribou Biosciences

Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. We are advancing our pipeline of off-the-shelf cell therapies from our CAR-T cell therapy platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases.

Established

2012

Company Size

51-200 employees